Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

403 ARTÍCULOS , VIENDO DEL 1 AL 15

Early-onset Alzheimers and cortical vision impairment in a woman with valosin-containing protein disease associated with 2 APOE ε4/APOE ε4 genotype

Shamirian S, Nalbandian A, Khare M, Castellani R, Kim R, Kimonis VE.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):90-3. doi: 10.1097/WAD.0b013e318298e54f.

A case of globular glial tauopathy presenting clinically as alzheimer disease

SantaCruz KS, Rottunda SJ, Meints JP, Bearer EL, Bigio EH, McCarten JR.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):82-4. doi: 10.1097/WAD.0b013e318298e531.

Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?

Cary MS, Rubright JD, Grill JD, Karlawish J.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):70-4. doi: 10.1097/WAD.0000000000000047.

Impact of a therapeutic educational program on quality of life in Alzheimer's disease: results of a pilot study

Villars H, Dupuy C, Perrin A, Vellas B, Nourhashemi F.

J Alzheimers Dis. 2015;43(1):167-76. doi: 10.3233/JAD-141179.

Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia

Liu-Seifert H, Siemers E, Sundell K, Price K, Han B, Selzler K, Aisen P, Cummings J, Raskin J, Mohs R.

J Alzheimers Dis. 2015;43(3):949-55. doi: 10.3233/JAD-140792.

Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study

Sousa MF, Santos RL, Nogueira ML, Belfort T, Rosa RD, Torres B, Simões P, Mograbi DC, Laks J, Dourado MC.

J Alzheimers Dis. 2015;43(3):905-13. doi: 10.3233/JAD-140342.

Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia

Spehl TS, Frings L, Hellwig S, Weiller C, Hüll M, Meyer PT, Amtage F.

Clin Nucl Med. 2015 Jan;40(1):e27-33. doi: 10.1097/RLU.0000000000000554.

Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis

Zhu XC, Yu Y, Wang HF, Jiang T, Cao L, Wang C, Wang J, Tan CC, Meng XF, Tan L, Yu JT.

J Alzheimers Dis. 2015;44(1):163-74. doi: 10.3233/JAD-141377.

Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study

Olde Rikkert MG, Verhey FR, Blesa R, von Arnim CA, Bongers A, Harrison J, Sijben J, Scarpini E, Vandewoude MF, Vellas B, Witkamp R, Kamphuis PJ, Scheltens P.

J Alzheimers Dis. 2015;44(2):471-80. doi: 10.3233/JAD-141305.

Trazodone and cognitive performance in Alzheimer disease

Camargos EF, Quintas JL, Louzada LL, Naves JO, Furioso AC, Nóbrega OT.

J Clin Psychopharmacol. 2015 Feb;35(1):88-9. doi: 10.1097/JCP.0000000000000237.

Downsizing of lean body mass is a key determinant of Alzheimer's disease

Ingenbleek Y, Bernstein LH.

J Alzheimers Dis. 2015;44(3):745-54. doi: 10.3233/JAD-141950.

The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial

Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S.

J Alzheimers Dis. 2015;44(4):1157-69. doi: 10.3233/JAD-142265.

Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor

Grossberg GT, Farlow MR, Meng X, Velting DM.

Curr Alzheimer Res. 2015;12(1):53-60. doi: 10.2174/1567205011666141218122835.

New horizons in the management of Alzheimer disease

Morley JE.

J Am Med Dir Assoc. 2015 Jan;16(1):1-5. doi: 10.1016/j.jamda.2014.10.022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias